7TF3

Cryo-EM structure of SARS-CoV-2 Kappa (B.1.617.1) Q484A spike protein

Summary for 7TF3

Entry DOI	10.2210/pdb7tf3/pdb
EMDB information	25860
Descriptor	Spike glycoprotein, 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, 2-acetamido-2-deoxy-beta-D-glucopyranose (3 entities in total)
Functional Keywords	sars-cov-2, glycoprotein, fusion protein, viral protein
Biological source	Severe acute respiratory syndrome coronavirus 2
Total number of polymer chains	3
Total formula weight	439340.06
Authors	Zhu, X.,Saville, J.W.,Mannar, D.,Srivastava, S.S.,Berezuk, A.M.,Demers, J.P.,Zhou, S.,Tuttle, K.S.,Subramaniam, S. (deposition date: 2022-01-06, release date: 2022-03-30)
Primary citation	Saville, J.W.,Mannar, D.,Zhu, X.,Srivastava, S.S.,Berezuk, A.M.,Demers, J.P.,Zhou, S.,Tuttle, K.S.,Sekirov, I.,Kim, A.,Li, W.,Dimitrov, D.S.,Subramaniam, S. Structural and biochemical rationale for enhanced spike protein fitness in delta and kappa SARS-CoV-2 variants. Nat Commun, 13:742-742, 2022 Cited by PubMed: 35136050 DOI: 10.1038/s41467-022-28324-6 PDB entries with the same primary citation
Experimental method	ELECTRON MICROSCOPY (2.25 Å)

Structure validation